We are live on ! Find out more
MG

Mather Group Portfolio holdings

AUM $10B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+15.14%
3 Year Est. Return
+41.01%
5 Year Est. Return
+34.1%
10 Year Est. Return
+114.21%
AUM
$8.65B
AUM Growth
+$943M
Cap. Flow
+$1.08B
Cap. Flow %
12.43%
Top 10 Hldgs %
53.77%
Holding
1,881
New
134
Increased
640
Reduced
468
Closed
88

Sector Composition

Rank Sector Weight
1 Industrials 7.97%
2 Technology 2.06%
3 Financials 1.62%
4 Consumer Staples 1.51%
5 Consumer Discretionary 0.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVT icon
1526
Avnet
AVT
$7.33B
$2.65K ﹤0.01%
55
ROCK icon
1527
Gibraltar Industries
ROCK
$1.34B
$2.64K ﹤0.01%
45
-151
-77% -$9.39K
WPP icon
1528
WPP
WPP
$4.04B
$2.62K ﹤0.01%
69
-96
-58% -$4.27K
FLYW icon
1529
Flywire
FLYW
$1.96B
$2.61K ﹤0.01%
+275
New +$4.33K
ELME
1530
Elme Communities
ELME
$132M
$2.61K ﹤0.01%
150
CFR icon
1531
Cullen/Frost Bankers
CFR
$10.3B
$2.57K ﹤0.01%
21
-25
-54% -$3.36K
THR
1532
DELISTED
Thermon Group Holdings
THR
$2.56K ﹤0.01%
+92
New +$2.66K
WOR icon
1533
Worthington Enterprises
WOR
$2.76B
$2.56K ﹤0.01%
51
MP icon
1534
MP Materials
MP
$7.35B
$2.54K ﹤0.01%
104
-396
-79% -$9.2K
FTDR icon
1535
Frontdoor
FTDR
$5.02B
$2.54K ﹤0.01%
66
HOPE icon
1536
Hope Bancorp
HOPE
$1.72B
$2.51K ﹤0.01%
240
PFBC icon
1537
Preferred Bank
PFBC
$1.22B
$2.51K ﹤0.01%
30
FRME icon
1538
First Merchants
FRME
$2.72B
$2.51K ﹤0.01%
62
ITCI
1539
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.51K ﹤0.01%
+19
New +$2.37K
RPRX icon
1540
Royalty Pharma
RPRX
$26.1B
$2.49K ﹤0.01%
+80
New +$2.54K
GNMA icon
1541
iShares GNMA Bond ETF
GNMA
$422M
$2.46K ﹤0.01%
56
-817
-94% -$35.4K
LCII icon
1542
LCI Industries
LCII
$2.51B
$2.45K ﹤0.01%
28
-74
-73% -$7.43K
BRZE icon
1543
Braze
BRZE
$2.45B
$2.42K ﹤0.01%
67
-14
-17% -$563
NOMD icon
1544
Nomad Foods
NOMD
$1.64B
$2.4K ﹤0.01%
122
MMS icon
1545
Maximus
MMS
$3.14B
$2.38K ﹤0.01%
35
-26
-43% -$1.85K
LGF.A
1546
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$2.38K ﹤0.01%
269
CRNX icon
1547
Crinetics Pharmaceuticals
CRNX
$8.86B
$2.35K ﹤0.01%
+70
New +$2.61K
AGIO icon
1548
Agios Pharmaceuticals
AGIO
$2.16B
$2.34K ﹤0.01%
+80
New +$2.65K
DNOW icon
1549
DNOW Inc
DNOW
$2.63B
$2.34K ﹤0.01%
137
MYI icon
1550
BlackRock MuniYield Quality Fund III
MYI
$709M
$2.33K ﹤0.01%
212

Similar funds

Mather Group's Q1 2025 Portfolio in Review

As of Q1 2025, Mather Group held 1,881 positions worth $8.65B, up 12% from $7.71B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Mather Group deployed $1.08B of net new capital in Q1 2025, opening 134 new positions and adding to 640 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 14 shares worth $11.2M.

By sector, the portfolio is most concentrated in Industrials at 8% of assets, up from 0.93% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $85.5M trimmed.

  • Mather Group's largest Q1 2025 buy was Berkshire Hathaway Class A: 14 shares worth $11.2M.
  • Mather Group added most to Lennox International in Q1 2025, an estimated $645M increase.
  • Mather Group's biggest Q1 2025 reduction was Vanguard FTSE Europe ETF, cutting an estimated $85.5M.
  • Mather Group fully exited American Healthcare REIT in Q1 2025, selling an estimated $198K.
  • Mather Group's ten largest holdings make up 54% of its $8.65B portfolio in Q1 2025.
  • Mather Group opened 134 new positions and closed 88 in Q1 2025.
  • Mather Group's portfolio value rose 12% quarter-over-quarter to $8.65B.

Based on Mather Group's 13F filing for Q1 2025, filed 25 Apr 2025.